Connect Biopharma Holdings Limited - PE Ratio

The PE Ratio as of June 2026 (TTM) for Connect Biopharma Holdings Limited (CNTB) is -1.74

According to Connect Biopharma Holdings Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.74. This represents a change of 261.31% compared to the average of -0.48 of the last 4 quarters.

Connect Biopharma Holdings Limited (CNTB) Historical PE Ratio (quarterly & annually)

How has CNTB PE Ratio performed in the past?

The mean historical PE Ratio of Connect Biopharma Holdings Limited over the last ten years is -2.06. The current -1.74 PE Ratio has changed 8.33% with respect to the historical average. Over the past ten years (40 quarters), CNTB's PE Ratio was at its highest in in the June 2024 quarter at 2.57. The PE Ratio was at its lowest in in the June 2020 quarter at -23112.50.

Connect Biopharma Holdings Limited (CNTB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Connect Biopharma Holdings Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Connect Biopharma Holdings Limited (CNTB) Average PE Ratio

How has CNTB PE Ratio performed in the past?

The current PE Ratio of Connect Biopharma Holdings Limited (CNTB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Connect Biopharma Holdings Limited (CNTB) PE Ratio vs. Peers

How is CNTB’s PE Ratio compared to its peers?

Connect Biopharma Holdings Limited’s PE Ratio is greater than InflaRx N.V. (-2.59), less than ImageneBio Inc (-1.29), greater than Kalaris Therapeutics Inc (-2.20), greater than Shattuck Labs, Inc. (-7.86), greater than Artiva Biotherapeutics, Inc. (-2.77), less than Sutro Biopharma, Inc. (-0.10), less than Metagenomi, Inc. Common Stock (-0.52), less than Context Therapeutics Inc. (-1.49), less than Quince Therapeutics, Inc. (-0.15), greater than Ovid Therapeutics Inc. (-6.56),

Build a custom stock screener for Connect Biopharma Holdings Limited (CNTB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Connect Biopharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Connect Biopharma Holdings Limited (CNTB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Connect Biopharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.